Internal Medicine and Psoriasis

Psoriasis is incurable, it responds well to many topical and systemic treatments. Cyclosporine may be used for severe, difficult-to-treat cases of widespread psoriasis. Improvement and results may be very rapid in onset. Major possible side effects include kidney and blood-pressure problems. Methotrexate is a common drug used for rheumatoid arthritis, and it has been used effectively for many years in psoriasis. The drug may cause liver and lung damage. Close physician monitoring and monthly to quarterly visits and labs are generally required.

  • Psoriasis and Cancer
  • Metabolic syndrome and psoriasis
  • Psoriasis and cardiovascular disease
  • Microbiome and Psoriasis

Related Conference of Internal Medicine and Psoriasis

April 16-17, 2026

9th World Cosmetic and Dermatology Congress

Paris, France
June 15-16, 2026

COSMETIC DERMATOLOGY 2026

Paris, France
June 22-23, 2026

28th World Dermatology and Aesthetic Congress

London, UK
June 25-26, 2026

27th World Dermatology Congress

Paris, France
July 20-21, 2026

20th International Conference on Alzheimers Disease & Dementia

Amsterdam, Netherlands
August 25-26, 2026

26th European Dermatology Congress

Paris, France
September 23-24, 2026

9th International Dermatology Conference: Skin and Body

Barcelona, Spain

Internal Medicine and Psoriasis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in